LISTING ON THE OFFICIAL LIST OF NASDAQ HELSINKI: DNA PLC ON

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
LISTING ON THE OFFICIAL LIST OF NASDAQ HELSINKI: DNA PLC ON 2 DECEMBER 2016

EXCHANGE NOTICE,  1 DECEMBER 2016  SHARES

LISTING ON THE OFFICIAL LIST OF NASDAQ HELSINKI: DNA PLC ON 2 DECEMBER 2016

The shares of DNA Plc will be listed on the Official List of Nasdaq Helsinki on Friday 2 December 2016. The shares of DNA Plc will be traded for the last time on the Prelist on Thursday 1 December 2016.

Basic information on DNA Plc as of 2 December 2016:

Trading code: DNA Issuer code: DNA ISIN-code: FI4000062385 Orderbook id: 129110 Market Segment: OMX HEL Equities CCP / 181 Tick Size Table: XHEL Equities EUR, FESE2 / 218 MIC: XHEL Number of shares: 132.031.957 Listing date on the Official List: 2 December 2016

Industry: 6000 Telecommunications ICB Supersector: 6500 Telecommunications  Market Cap Segment: Large Cap Managing director: Jukka Leinonen Address: Läkkisepäntie 21                FI-00620 Helsinki                FINLAND Phone: +358 44 0440 Internet: www.dna.fi

Nasdaq Helsinki Oy, Issuer Surveillance, survo@nasdaq.com , +358 9 6166 7260

* * * * * * * * * * * * * * * * * *

TIEDOTE,  1.12.2016  OSAKKEET

DNA OYJ NASDAQ HELSINGIN PÖRSSILISTALLE 2.12.2016

DNA Oyj listautuu Nasdaq Helsingin pörssilistalle perjantaina 2.12.2016. DNA Oyj:n osake on viimeistä kertaa kaupankäynnin kohteena Prelistalla torstaina 1.12.2016.

DNA Oyj:n perustiedot 2.12.2016:

Kaupankäyntitunnus: DNA Liikkeeseenlaskijatunnus: DNA ISIN-koodi: FI4000062385 id: 129110 Segmentti: OMX HEL Equities CCP / 181 Tikkivälitaulukko: XHEL Equities EUR, FESE2 / 218 MIC: XHEL Osakkeiden lukumäärä: 132.031.957 Kaupankäynti pörssilistalla alkaa: 2.12.2016

Toimiala: 6000 Tietoliikennepalvelut ICB Ylätoimialaluokka: 6500 Tietoliikennepalvelut  Markkina-arvoluokka: Suuret yhtiöt Toimitusjohtaja: Jukka Leinonen Osoite: Läkkisepäntie 21             00620 Helsinki Puhelin: 044 0440 Internet: www.dna.fi  

Nasdaq Helsinki Oy, Issuer Surveillance, survo@nasdaq.com , +358 9 6166 7260

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Explore Rights in Symbotic Class Action

Updated Category News Views 77

Understanding the Class Action Lawsuit for Symbotic Inc. Investors in Symbotic Inc. (NASDAQ:SYM) are currently facing significant concerns regarding recent developments within the company. A class action lawsuit has been initiated in the U.S. District Court for the District of Massachusetts, aimed at those investors who purchased securities between the specified dates....

Continue Reading
Egypt's President Sisi Reflects on IMF Agreement Amid Crisis

Updated Category News Views 169

Egypt's Economic Landscape Under Scrutiny In light of unprecedented regional challenges, Egyptian President Abdel Fattah al-Sisi has raised concerns regarding the nation's ongoing agreement with the International Monetary Fund (IMF). The $8 billion financial support program, signed amidst economic turbulence, may be revisited if the expectations of global financial...

Continue Reading
Insights into Mastercard's Recent Options Trading Dynamics

Updated Category News Views 102

Mastercard's Options Activity: What's Happening? Recently, the options market has seen significant movement from large investors, commonly referred to as "whales." This activity indicates a largely bearish sentiment towards Mastercard. In our analysis of the recent trades involving Mastercard MA, we identified eight significant transactions. Interestingly, none of these...

Continue Reading
Coave Therapeutics Raises Significant Funding for Genetic Breakthroughs

Updated Category News Views 292

Coave Therapeutics Secures Major Investment to Propel Innovation Coave Therapeutics, a pioneer in the realm of genetic medicines, has successfully raised €32 million (approximately $33 million) in a Series A financing round. This funding was notably co-led by Novo Holdings A/S and Bpifrance, with additional contributions from leading investors in the US and EU,...

Continue Reading
Strive Expands with MSTR True North Acquisition and Leadership Change

Updated Category News Views 140

Strive's Exciting Acquisition of MSTR True North Inc. Strive, Inc. has made waves in the financial technology sector with its strategic acquisition of MSTR True North Inc. This move marks a pivotal moment in Strive's journey, enhancing its commitment to Bitcoin advocacy and marking a significant step forward in the realm of Digital Capital and Digital Credit. Leadership...

Continue Reading